413 related articles for article (PubMed ID: 11675036)
1. Neuroprotective effect of treatment with human albumin in permanent focal cerebral ischemia: histopathology and cortical perfusion studies.
Liu Y; Belayev L; Zhao W; Busto R; Belayev A; Ginsberg MD
Eur J Pharmacol; 2001 Oct; 428(2):193-201. PubMed ID: 11675036
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
[TBL] [Abstract][Full Text] [Related]
3. MRZ 2/579, a novel uncompetitive N-methyl-D-aspartate antagonist, reduces infarct volume and brain swelling and improves neurological deficit after focal cerebral ischemia in rats.
Liu Y; Belayev L; Zhao W; Busto R; Ginsberg MD
Brain Res; 2000 Apr; 862(1-2):111-9. PubMed ID: 10799675
[TBL] [Abstract][Full Text] [Related]
4. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
Belayev L; Liu Y; Zhao W; Busto R; Ginsberg MD
Stroke; 2001 Feb; 32(2):553-60. PubMed ID: 11157196
[TBL] [Abstract][Full Text] [Related]
5. Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses.
Belayev L; Pinard E; Nallet H; Seylaz J; Liu Y; Riyamongkol P; Zhao W; Busto R; Ginsberg MD
Stroke; 2002 Apr; 33(4):1077-84. PubMed ID: 11935064
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection by LY341122, a novel inhibitor of lipid peroxidation, against focal ischemic brain damage in rats.
Huh PW; Belayev L; Zhao W; Clemens JA; Panetta JA; Busto R; Ginsberg MD
Eur J Pharmacol; 2000 Feb; 389(1):79-88. PubMed ID: 10686299
[TBL] [Abstract][Full Text] [Related]
7. Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats.
Belayev L; Busto R; Zhao W; Clemens JA; Ginsberg MD
J Neurosurg; 1997 Oct; 87(4):595-601. PubMed ID: 9322848
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
9. The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats.
Huh PW; Belayev L; Zhao W; Busto R; Saul I; Ginsberg MD
Brain Res; 1998 Aug; 804(1):105-13. PubMed ID: 9729310
[TBL] [Abstract][Full Text] [Related]
10. Caffeinol confers cortical but not subcortical neuroprotection after transient focal cerebral ischemia in rats.
Belayev L; Khoutorova L; Zhang Y; Belayev A; Zhao W; Busto R; Ginsberg MD
Brain Res; 2004 May; 1008(2):278-83. PubMed ID: 15145766
[TBL] [Abstract][Full Text] [Related]
11. Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion.
Sayeed I; Wali B; Stein DG
Restor Neurol Neurosci; 2007; 25(2):151-9. PubMed ID: 17726274
[TBL] [Abstract][Full Text] [Related]
12. Early administration of a second-generation perfluorochemical decreases ischemic brain damage in a model of permanent middle cerebral artery occlusion in the rat.
Woitzik J; Weinzierl N; Schilling L
Neurol Res; 2005 Jul; 27(5):509-15. PubMed ID: 15978177
[TBL] [Abstract][Full Text] [Related]
13. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
[TBL] [Abstract][Full Text] [Related]
14. Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats.
Lee EJ; Chen HY; Wu TS; Chen TY; Ayoub IA; Maynard KI
J Neurosci Res; 2002 Jun; 68(5):636-45. PubMed ID: 12111854
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia.
Belayev L; Zhao W; Pattany PM; Weaver RG; Huh PW; Lin B; Busto R; Ginsberg MD
Stroke; 1998 Dec; 29(12):2587-99. PubMed ID: 9836772
[TBL] [Abstract][Full Text] [Related]
16. Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion.
Sayeed I; Guo Q; Hoffman SW; Stein DG
Ann Emerg Med; 2006 Apr; 47(4):381-9. PubMed ID: 16546625
[TBL] [Abstract][Full Text] [Related]
17. High-dose methylprednisolone treatment in experimental focal cerebral ischemia.
Slivka AP; Murphy EJ
Exp Neurol; 2001 Jan; 167(1):166-72. PubMed ID: 11161604
[TBL] [Abstract][Full Text] [Related]
18. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
Petty MA; Neumann-Haefelin C; Kalisch J; Sarhan S; Wettstein JG; Juretschke HP
Eur J Pharmacol; 2003 Aug; 474(1):53-62. PubMed ID: 12909195
[TBL] [Abstract][Full Text] [Related]
19. A selective endothelin ET(A) receptor antagonist, SB 234551, improves cerebral perfusion following permanent focal cerebral ischemia in rats.
Zhang Y; Belayev L; Zhao W; Irving EA; Busto R; Ginsberg MD
Brain Res; 2005 May; 1045(1-2):150-6. PubMed ID: 15910773
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic time window of neuroprotection by non-competitive AMPA antagonists in transient and permanent focal cerebral ischemia in rats.
Matucz E; Móricz K; Gigler G; Benedek A; Barkóczy J; Lévay G; Hársing LG; Szénási G
Brain Res; 2006 Dec; 1123(1):60-7. PubMed ID: 17064671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
